Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
about
Optic neuritis associated with adalimumab in the treatment of uveitis.Neurological disorders and inflammatory bowel diseasesInitiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study.A case report of adalimumab-associated optic neuritis.Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.Optic neuritis due to immunobiologics: first Brazilian case reportCNS Demyelination with TNF-α BlockersNeurological complications of biologic therapy in psoriasis: a review.A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature.Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors.Orbital and optic nerve complications of inflammatory bowel disease.Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.Adverse reactions to biologic agents and their medical management.Biologic Therapy for HLA-B27-associated Ocular Disorders.Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease.Optic neuritis in a psoriatic arthritis patient treated by infliximab.2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.Irreversible optic neuritis after infliximab treatment in a patient with ulcerative colitis.Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis
P2860
Q33681462-C7CBF8EB-857C-442B-B63A-5BCFDB9DFE11Q33958822-D9849CF8-A7D5-40A8-A379-25C8865937DCQ34081364-C5FCAB74-C76B-401A-9125-4922C2519EB3Q36223187-F4BA8856-EFC5-4A49-AF82-60020257236AQ37118403-D392CDFE-A3D5-4A23-9C21-7D31A021D67AQ37420739-DD6BD861-36BA-407E-9E89-6CE7767F30ACQ37719132-72CA1F0A-E2FE-42A8-9C46-4C5C3F20291AQ37781282-6501A53A-9698-4973-9D53-0BDFD31C2BFFQ37814549-3BBF4B37-9F77-44A4-A795-1A8F047FA03DQ37831814-F416B755-C7D7-4CBE-B9E9-0E2CA28B6888Q37911726-E84DE6DD-AADC-41A7-A630-20BA6C459F8CQ38053517-FFE746D8-40C9-4E50-B5F1-038CCAD39572Q38099248-3BF4F806-7FF8-4AB6-970A-41DF905BEFFFQ38238948-E1430C08-A5CB-4816-838F-470FB133DF20Q38982632-F97C92E4-2E5D-4C60-B1F9-32FD192BB408Q43132889-2D878AB9-DD9B-43B7-9CF8-49E66B7195E7Q46816298-3600EDD8-574F-4AAF-AA04-99482349B8E7Q48089791-4883899C-47D4-4935-9B93-D37F492B9ABFQ48099880-313E4C68-C1BF-4F3B-BF5C-CE666B4BE9AFQ57267898-0FAAB664-F698-47D9-A0FC-2120A3FDA798
P2860
Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
@ast
Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
@en
type
label
Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
@ast
Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
@en
prefLabel
Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
@ast
Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
@en
P2093
P2860
P356
P1476
Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
@en
P2093
Ayhan Dinc
Gungor Sobaci
Hakan Erdem
Ismail Simsek
P2860
P304
P356
10.1136/ARD.2006.066787
P407
P577
2007-04-24T00:00:00Z